Shannen Vixler, ARNP
NPI 1528091998 · Family Nurse Practitioner · Fort Myers, FL
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1528091998
- Entity type
- Individual
- Primary specialty
- Family Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- ARNP
- Sex
- Female
- Sole proprietor
- No
- License
- ARNP9198349 (FL)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
16,189 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 8,371 | $6 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 2,082 | $82 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 1,745 | $44 |
| Biopsy of Related Skin Growth, First Growth11102 | 1,439 | $88 |
| Biopsy of Related Skin Growth, Each Additional Growth11103 | 1,248 | $45 |
| Destruction of Cancer Skin Growth of Trunk, Arms, Or Legs, 1.1-2.0 Cm17262 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 356 | 265 |
| Mupirocin | 312 | 246 |
| Ketoconazole | 122 | 83 |
| Fluocinonide | 76 | 52 |
| Minocycline Hcl | 72 | 53 |
| Clobetasol Propionate | 38 | 28 |
| Sulfamethoxazole/Trimethoprimbrand: Sulfamethoxazole-Trimethoprim | 28 | 18 |
| Gentamicin Sulfate | 26 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$720 across 23 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-07-09
- Last updated
- 2011-01-06
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.